193 related articles for article (PubMed ID: 8888732)
21. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
[TBL] [Abstract][Full Text] [Related]
22. [Gene point mutation in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum].
Zhang ZX; Yang YM; Liu H
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(2):87-9. PubMed ID: 12571992
[TBL] [Abstract][Full Text] [Related]
23. Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.
Japrung D; Leartsakulpanich U; Chusacultanachai S; Yuthavong Y
Antimicrob Agents Chemother; 2007 Dec; 51(12):4356-60. PubMed ID: 17875995
[TBL] [Abstract][Full Text] [Related]
24. Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum.
Yuthavong Y; Vilaivan T; Chareonsethakul N; Kamchonwongpaisan S; Sirawaraporn W; Quarrell R; Lowe G
J Med Chem; 2000 Jul; 43(14):2738-44. PubMed ID: 10893311
[TBL] [Abstract][Full Text] [Related]
25. Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance.
Santos-Filho OA; de Alencastro RB; Figueroa-Villar JD
Biophys Chem; 2001 Jul; 91(3):305-17. PubMed ID: 11551441
[TBL] [Abstract][Full Text] [Related]
26. Cloning and heterologous expression of Plasmodium ovale dihydrofolate reductase-thymidylate synthase gene.
Tirakarn S; Riangrungroj P; Kongsaeree P; Imwong M; Yuthavong Y; Leartsakulpanich U
Parasitol Int; 2012 Jun; 61(2):324-32. PubMed ID: 22234170
[TBL] [Abstract][Full Text] [Related]
27. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
Basco LK; Le Bras J
Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
[TBL] [Abstract][Full Text] [Related]
28. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
Wooden JM; Hartwell LH; Vasquez B; Sibley CH
Mol Biochem Parasitol; 1997 Mar; 85(1):25-40. PubMed ID: 9108546
[TBL] [Abstract][Full Text] [Related]
29. Genome comparison of progressively drug resistant Plasmodium falciparum lines derived from drug sensitive clone.
Toteja R; Nair L; Bhasin V
Mem Inst Oswaldo Cruz; 2001 Apr; 96(3):427-33. PubMed ID: 11313656
[TBL] [Abstract][Full Text] [Related]
30. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P
J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261
[TBL] [Abstract][Full Text] [Related]
31. Functional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparum.
Auliff AM; Balu B; Chen N; O'Neil MT; Cheng Q; Adams JH
PLoS One; 2012; 7(7):e40416. PubMed ID: 22792308
[TBL] [Abstract][Full Text] [Related]
32. [Presence of pyrimethamine and cycloguanil resistance genotype in West Africa? Evidence of a single mutation 59Arg in the dhfr gene of Plasmodium falciparum].
Pinheiro L; Rosário VE
Acta Med Port; 2003; 16(4):235-8. PubMed ID: 22226208
[TBL] [Abstract][Full Text] [Related]
33. Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia.
Mkulama MA; Chishimba S; Sikalima J; Rouse P; Thuma PE; Mharakurwa S
Malar J; 2008 May; 7():87. PubMed ID: 18495008
[TBL] [Abstract][Full Text] [Related]
34. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
Fidock DA; Nomura T; Wellems TE
Mol Pharmacol; 1998 Dec; 54(6):1140-7. PubMed ID: 9855645
[TBL] [Abstract][Full Text] [Related]
35. Molecular epidemiology of Plasmodium falciparum antifolate resistance in Vietnam: genotyping for resistance variants of dihydropteroate synthase and dihydrofolate reductase.
Masimirembwa CM; Phuong-dung N; Phuc BQ; Duc-Dao L; Sy ND; Sköld O; Swedberg G
Int J Antimicrob Agents; 1999 Aug; 12(3):203-11. PubMed ID: 10461838
[TBL] [Abstract][Full Text] [Related]
36. Mutant dihydrofolate reductase-thymidylate synthase genes in pyrimethamine-resistant Plasmodium falciparum with polymorphic chromosome duplications.
Tanaka M; Gu HM; Bzik DJ; Li WB; Inselburg J
Mol Biochem Parasitol; 1990 Aug; 42(1):83-91. PubMed ID: 2233901
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
Hekmat-Nejad M; Rathod PK
Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
[TBL] [Abstract][Full Text] [Related]
38. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
[TBL] [Abstract][Full Text] [Related]
39. Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine.
Gyang FN; Peterson DS; Wellems TE
Exp Parasitol; 1992 Jun; 74(4):470-2. PubMed ID: 1592095
[No Abstract] [Full Text] [Related]
40. Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine.
Snewin VA; England SM; Sims PF; Hyde JE
Gene; 1989 Mar; 76(1):41-52. PubMed ID: 2663650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
